Jean Soulier(@jeansoulier1) 's Twitter Profile Photo

Our study on clonal evolution in Fanconi anemia is out in Cell Stem Cell. In the FA background of chromosomal instability & HSC attrition, trisomy 1q/MDM4-driven p53 downregulation yields clonal hematopoiesis, preceding sAML.
authors.elsevier.com/a/1gX1h6tu0Cm4…
1/2

Our study on clonal evolution in Fanconi anemia is out in @CellStemCell. In the FA background of chromosomal instability & HSC attrition, trisomy 1q/MDM4-driven p53 downregulation yields clonal hematopoiesis, preceding sAML.
authors.elsevier.com/a/1gX1h6tu0Cm4…
#BMFsm #leusm #mdssm #AMLsm 1/2
account_circle
British Journal of Haematology(@BrJHaem) 's Twitter Profile Photo

Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: the TELESTO study onlinelibrary.wiley.com/doi/10.1111/bj…

Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: the TELESTO study onlinelibrary.wiley.com/doi/10.1111/bj… #mdssm #leusm
account_circle
Nicolas Duployez(@NicolasDuployez) 's Twitter Profile Photo

Finally out in AmericanJournalofHematology!
In adults with :
1⃣hypereosinophilic syndromes AND
2⃣“myeloid” features (splenomegaly, ⇑ tryptase, other CBC abnormality, corticoR) AND
3⃣lacking tyrosine kinase fusions
👉>50 % have mutations in the JAK-STAT pathway

Finally out in @AjHematology! 
In adults with :
1⃣hypereosinophilic syndromes AND 
2⃣“myeloid” features (splenomegaly, ⇑ tryptase, other CBC abnormality, corticoR) AND 
3⃣lacking tyrosine kinase fusions
👉>50 % have mutations in the JAK-STAT pathway
#MDSsm #MPNsm #leusm #CEREO
account_circle
Katja Sockel(@KatjaSockel) 's Twitter Profile Photo

Practice-changing results at Plenary session:
Luspatercept moves into 1st line for transfusion-dependent low-risk MDS!
Superior transfusion independence compared to Epoetin alfa!
Important step for patients!
@ matteodellaporta G Garcia-Manero MDS Foundation

Practice-changing results at #EHA2023 Plenary session: 
Luspatercept moves into 1st line for transfusion-dependent low-risk MDS! 
Superior transfusion independence compared to Epoetin alfa!
Important step for patients!
@ matteodellaporta @garciamanero @MDSFoundation 
#MDSsm
account_circle
Amer Zeidan MBBS,MHS ‏عامر زيدان(@Dr_AmerZeidan) 's Twitter Profile Photo

Who was your childhood/teenage years science hero? Carl Sagan here! (& didn’t choose to work on because he died from it, just a coincidence)…

Who was your childhood/teenage years science hero?   Carl Sagan here! (& didn’t choose to work on #MDSsm because he died from it, just a coincidence)…
account_circle
Maria Sirenko(@MariaSirenko) 's Twitter Profile Photo

Which patients are most likely to have UBA1 mutations associated with syndrome?

Our study now out in Blood Journal: Molecular and clinical presentation of UBA1-mutated MDS by Elli Papaemmanuil, PhD, Elsa Bernard, Maria Creignou, David Beck, MDS IWG-PM & MDS Foundation

Which #MDSsm patients are most likely to have UBA1 mutations associated with #VEXAS syndrome?

Our study now out in @BloodJournal: Molecular and clinical presentation of UBA1-mutated MDS by @PapaemmanuilLab, @Elsa2Bernard, @MariaCreignou, David Beck, MDS IWG-PM & @MDSFoundation
account_circle
Sankalp Arora MD(@sankalparoramd) 's Twitter Profile Photo

So excited to present the five year follow up results of phase 2 single arm clinical trial conducted MD Anderson Cancer Center evaluating Aza + Rux in MDS/MPN overlap syndromes!

ORR : 54%, DoR : 35 months
mOS: 31.8 mo

Link : ash.confex.com/ash/2023/webpr…



So excited to present the five year follow up results of phase 2 single arm clinical trial conducted @MDAndersonNews evaluating Aza + Rux in MDS/MPN overlap syndromes! #ASH23 

ORR : 54%, DoR : 35 months
mOS: 31.8 mo 

Link : ash.confex.com/ash/2023/webpr…

#leusm
#mdssm 
#mpnsm
account_circle
Dr. Uma Borate: Associate Professor(@beatalleukemia) 's Twitter Profile Photo

I ❤️ my patients and their caregivers. They are the most amazing, brave & kind people I know. What a privilege to take care of & patients. ⁦The James

I ❤️ my patients and their caregivers. They are the most amazing, brave & kind people I know. What a privilege to take care of #leusm & #mdssm patients. ⁦@OSUCCC_James⁩
account_circle
British Journal of Haematology(@BrJHaem) 's Twitter Profile Photo

Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: a Mayo Clinic series

onlinelibrary.wiley.com/doi/10.1111/bj…
Mrinal Patnaik Mark Litzow Aref Al-Kali Naseema Gangat

Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: a Mayo Clinic series 

onlinelibrary.wiley.com/doi/10.1111/bj… 
#leusm #mdssm #DDX41 @MrinalPatnaik @MRLitzow @AlkaliDr @n_gangat
account_circle
Yazan Madanat, MD(@madanatyazan) 's Twitter Profile Photo

Entertaining collegial debate alert! Maximilian Stahl Dana-Farber News dives into the role for frontline luspatercept use for ! 🚀 Energizing insights, engaging discussion! 👇 ! MD Education US Focus 5th annual meeting 👏👏🎊🎊It’s all about the Win 😂👏

Entertaining collegial debate alert! @MaxStahlMD @DanaFarberNews dives into the role for frontline luspatercept use for #MDSsm! 🚀 Energizing insights, engaging discussion! 👇 ! #MedTwitter @_MDEducation US Focus 5th annual meeting 👏👏🎊🎊It’s all about the Win 😂👏
account_circle